# Once-Daily Asenapine for Schizophrenia

> **NCT01549041** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 30 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Asenapine 10 mg daily in the evening
- **DRUG:** Asenapine 5 mg twice daily

## Key facts

- **NCT ID:** NCT01549041
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549041, "Once-Daily Asenapine for Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01549041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*